MOTS-c
Synthetic peptide studied in animal and cell models for metabolic optimization and exercise capacity enhancement
Last updated: March 1, 2026
- Compound
- MOTS-c
- Class
- Longevity peptide
- Summary
- Synthetic peptide studied in animal and cell models for metabolic optimization, exercise capacity enhancement, longevity-associated signaling.
- Mechanism
- Nuclear Translocation & Gene Regulation
- Research Status
- Preclinical
- Routes Studied
- Subcutaneous injection
- Evidence Level
- Preclinical-promising · Clinically unproven
What Should You Know About MOTS-c?
- What is MOTS-c?
- MOTS-c is a synthetic peptide studied in animal and cell models for metabolic optimization and exercise capacity enhancement.
- Is MOTS-c clinically proven?
- No. Human evidence remains limited and does not establish MOTS-c as clinically proven.
- What has MOTS-c been studied for?
- MOTS-c has been studied in preclinical models of metabolic optimization, exercise capacity enhancement, longevity-associated signaling. These findings have not been confirmed in large-scale human trials.
- Is MOTS-c approved?
- No. MOTS-c is not an approved drug and remains a research compound.
What Is MOTS-c?
MOTS-c (Mitochondrial Open Reading Frame of the Twelve S rRNA-c) is a 16-amino acid peptide encoded within the mitochondrial genome, specifically within the 12S ribosomal RNA gene. Discovered in 2015 by Dr. Changhan David Lee and colleagues at the University of Southern California, MOTS-c represents a groundbreaking class of compounds known as mitochondrial-derived peptides (MDPs). Its discovery fundamentally changed the understanding of mitochondria from simple energy-producing organelles to active signaling...
Evidence Summary
MOTS-c has extensive preclinical evidence (50+ PubMed citations) but no human clinical trial data. Most claims exceed current evidence.
Evidence Breakdown
| Domain | Evidence Level |
|---|---|
| Metabolic Optimization | Animal studies |
| Exercise Capacity Enhancement | Animal studies |
| Longevity-Associated Signaling | Animal studies |
| Mitochondrial Function Support | Animal studies |
| Human clinical evidence | Limited |
| Safety data | Insufficient |
| Deep Research Score | 1.5 / 5 See full review |
Editorial Position
MOTS-c is best understood as a preclinical research compound with promising biological signals but limited human validation. Many online claims exceed the strength of available human evidence, and safety data remains incomplete. Any consideration of this compound should involve careful evaluation of individual context and medical guidance.
Regulatory Status Snapshot
- Not approved as a therapeutic drug by major regulators
- Safety profile not established in large human populations
Need help interpreting this evidence for your situation?
Talk to a SpecialistA deep research review for MOTS-c is not yet available. This compound profile is based on published peer-reviewed references listed below.
Browse all research reviewsWhat Has MOTS-c Been Studied For?
Research areas where MOTS-c has been investigated in published studies
-
Metabolic Optimization MOTS-c has been studied in animal models of metabolic optimization. These findings have not been confirmed in controlled human trials.
-
Exercise Capacity Enhancement MOTS-c has been studied in animal models of exercise capacity enhancement. These findings have not been confirmed in controlled human trials.
-
Longevity-Associated Signaling MOTS-c has been studied in animal models of longevity-associated signaling. These findings have not been confirmed in controlled human trials.
-
Mitochondrial Function Support MOTS-c has been studied in animal models of mitochondrial function support. These findings have not been confirmed in controlled human trials.
How Does MOTS-c Work?
These mechanisms have been observed in preclinical models. They are plausible but have not been linked to proven clinical outcomes in humans.
- 01 Folate Cycle Inhibition
- 02 Intracellular signaling
- 03 Enhanced Glucose Uptake & Insulin Sensitivity
- 04 Mitochondrial Biogenesis via PGC-1α
Not sure if MOTS-c is right for you?
A specialist can review the evidence, evaluate your medical context, and help you make an informed decision about MOTS-c.
Community Reports (Anecdotal)
Experiences shared here are self-reported and do not represent clinical evidence.
Rate MOTS-c
How Is MOTS-c Administered?
MOTS-c is available via Subcutaneous injection, auto-injector pen. Appropriate use and protocol should be determined by a qualified specialist.
What Are the Specifications of MOTS-c?
What Conditions Has MOTS-c Been Linked To?
Have Questions About MOTS-c?
Published studies on MOTS-c can be found on PubMed and other peer-reviewed databases. Our references section below lists key citations.
MOTS-c is available as a research compound in Thailand. Consult a qualified specialist to discuss whether it is appropriate for your needs.
A qualified specialist experienced with peptide therapies can help you understand the current evidence and determine suitability.
Ready to discuss MOTS-c with a specialist?
Get evidence-based guidance tailored to your health goals and medical context.
Book a Consultation Free initial consultation. No obligation.Reviewed by the Peptide Science Thailand Editorial Team.
Last reviewed: March 1, 2026